Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of COL-101 for the Treatment of Blepharitis in Patients With Facial Rosacea

NCT00560703 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT00560703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00560703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of COL-101 for the Treatment of Blepharitis in Patients With Facial Rosacea
Lead sponsor
Galderma R&D
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2007
Completion date
July 31, 2009
Enrollment
70 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

blepharitis, dry eye, meibomianitis